146 related articles for article (PubMed ID: 34128075)
1. Predictors of sinus rhythm 6 weeks after cardioversion of atrial fibrillation: a pre-planned post hoc analysis of the X-VeRT trial.
Cappato R; Ezekowitz MD; Hohnloser SH; Meng IL; Wosnitza M; Camm AAJ;
Europace; 2021 Oct; 23(10):1539-1547. PubMed ID: 34128075
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: a post hoc analysis of the X-VeRT trial.
Hohnloser SH; Cappato R; Ezekowitz MD; Evers T; Sahin K; Kirchhof P; Meng IL; van Eickels M; Camm AJ;
Europace; 2016 Feb; 18(2):184-90. PubMed ID: 26487668
[TBL] [Abstract][Full Text] [Related]
3. Comparing the delay with different anticoagulants before elective electrical cardioversion for atrial fibrillation/flutter.
Wall C; Jankowski T; Naruka V; Mota P
PLoS One; 2019; 14(1):e0210170. PubMed ID: 30605492
[TBL] [Abstract][Full Text] [Related]
4. Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation.
Pluymaekers NAHA; Dudink EAMP; Luermans JGLM; Meeder JG; Lenderink T; Widdershoven J; Bucx JJJ; Rienstra M; Kamp O; Van Opstal JM; Alings M; Oomen A; Kirchhof CJ; Van Dijk VF; Ramanna H; Liem A; Dekker LR; Essers BAB; Tijssen JGP; Van Gelder IC; Crijns HJGM;
N Engl J Med; 2019 Apr; 380(16):1499-1508. PubMed ID: 30883054
[TBL] [Abstract][Full Text] [Related]
5. Transesophageal echocardiographic predictors for maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation.
Verhorst PM; Kamp O; Welling RC; Van Eenige MJ; Visser CA
Am J Cardiol; 1997 May; 79(10):1355-9. PubMed ID: 9165157
[TBL] [Abstract][Full Text] [Related]
6. Rivaroxaban in atrial fibrillation cardioversion: insights from the X-VeRT trial.
Farag M; Gorog DA
Future Cardiol; 2015 Mar; 11(2):147-51. PubMed ID: 25760874
[TBL] [Abstract][Full Text] [Related]
7. Left atrial mechanical remodelling assessed as the velocity of left atrium appendage wall motion during atrial fibrillation is associated with maintenance of sinus rhythm after electrical cardioversion in patients with persistent atrial fibrillation.
Wałek P; Sielski J; Gorczyca I; Roskal-Wałek J; Starzyk K; Jaskulska-Niedziela E; Bartkowiak R; Wożakowska-Kapłon B
PLoS One; 2020; 15(1):e0228239. PubMed ID: 31995607
[TBL] [Abstract][Full Text] [Related]
8. Factors predicting maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation and flutter: a reanalysis with recently acquired data.
Arnar DO; Danielsen R
Cardiology; 1996; 87(3):181-8. PubMed ID: 8725311
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and predictors of persistent sinus rhythm after elective electrical cardioversion for atrial fibrillation.
Castrichini M; Restivo L; Fabris E; Massa L; Di Meola R; Beltrame D; De Luca A; Korcova R; Milo M; Sinagra G
J Cardiovasc Med (Hagerstown); 2021 Aug; 22(8):626-630. PubMed ID: 33882536
[TBL] [Abstract][Full Text] [Related]
10. Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation.
Cappato R; Ezekowitz MD; Klein AL; Camm AJ; Ma CS; Le Heuzey JY; Talajic M; Scanavacca M; Vardas PE; Kirchhof P; Hemmrich M; Lanius V; Meng IL; Wildgoose P; van Eickels M; Hohnloser SH;
Eur Heart J; 2014 Dec; 35(47):3346-55. PubMed ID: 25182247
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of the eXplore the efficacy and safety of once-daily oral riVaroxaban for the prEvention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion trial: A comparison of oral rivaroxaban once daily with dose-adjusted vitamin K antagonists in patients with nonvalvular atrial fibrillation undergoing elective cardioversion.
Ezekowitz MD; Cappato R; Klein AL; Camm AJ; Ma CS; Le Heuzey JY; Talajic M; Scanavacca MI; Vardas PE; Kirchhof P; Hohnloser SH; Hemmrich M; Lanius V; Meng IL; Wildgoose P; van Eickels M
Am Heart J; 2014 May; 167(5):646-52. PubMed ID: 24766973
[TBL] [Abstract][Full Text] [Related]
12. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion.
Opolski G; Stanisławska J; Górecki A; Swiecicka G; Torbicki A; Kraska T
Clin Cardiol; 1997 Apr; 20(4):337-40. PubMed ID: 9098591
[TBL] [Abstract][Full Text] [Related]
13. [Pericardioversion and catheter ablation use of rivaroxaban in light of X-VERT and VENTURE-AF trials].
Akıllı R; Demir M
Turk Kardiyol Dern Ars; 2017 Sep; 45(Suppl 4):15-23. PubMed ID: 28947726
[TBL] [Abstract][Full Text] [Related]
14. Delaying cardioversion following 4-week anticoagulation in case of persistent atrial fibrillation after a transcatheter ablation procedure to reduce silent cerebral thromboembolism: a single-center pilot study.
Pianelli M; Scaglione M; Anselmino M; Caponi D; Garcia P; Cesarani F; Toso E; Raimondo C; Halimi F; Leclercq JF; Gaita F
J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):785-9. PubMed ID: 21941200
[TBL] [Abstract][Full Text] [Related]
15. High maintenance rate of sinus rhythm after cardioversion in post-thyrotoxic chronic atrial fibrillation.
Nakazawa HK; Handa S; Nakamura Y; Oyanagi H; Hasegawa M; Ishikawa N; Ozaki O; Ito K
Int J Cardiol; 1987 Jul; 16(1):47-55. PubMed ID: 3610396
[TBL] [Abstract][Full Text] [Related]
16. Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm.
Beck-da-Silva L; de Bold A; Fraser M; Williams K; Haddad H
Can J Cardiol; 2004 Oct; 20(12):1245-8. PubMed ID: 15494777
[TBL] [Abstract][Full Text] [Related]
17. Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial.
Piccini JP; Stevens SR; Lokhnygina Y; Patel MR; Halperin JL; Singer DE; Hankey GJ; Hacke W; Becker RC; Nessel CC; Mahaffey KW; Fox KA; Califf RM; Breithardt G;
J Am Coll Cardiol; 2013 May; 61(19):1998-2006. PubMed ID: 23500298
[TBL] [Abstract][Full Text] [Related]
18. Prediction of sinus rhythm maintenance following DC-cardioversion of persistent atrial fibrillation - the role of atrial cycle length.
Meurling CJ; Roijer A; Waktare JE; Holmqvist F; Lindholm CJ; Ingemansson MP; Carlson J; Stridh M; Sörnmo L; Olsson SB
BMC Cardiovasc Disord; 2006 Mar; 6():11. PubMed ID: 16533393
[TBL] [Abstract][Full Text] [Related]
19. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
Capucci A; Villani GQ; Aschieri D; Rosi A; Piepoli MF
Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746
[TBL] [Abstract][Full Text] [Related]
20. Clinical, adrenergic and heart endocrine measures in chronic atrial fibrillation as predictors of conversion and maintenance of sinus rhythm after direct current cardioversion.
Theodorakis GN; Markianos M; Kouroubetsis CK; Livanis EG; Paraskevaidis IA; Kremastinos DT
Eur Heart J; 1996 Apr; 17(4):550-6. PubMed ID: 8733088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
